Synopsis:- Shares jumped up to 4.4% after strong Q3FY26 results and a 3:1 bonus announcement. Revenue rose 26% YoY to ₹406 crore, while profit climbed 35% to ₹42 crore. Patient volumes grew 14%, supported by strong B2B growth and rising contribution from specialty diagnostics.
The shares of a prominent healthcare company gained up 4.4 percent in today’s trading session after the company reported strong Q3FY26 and also recommended a bonus in the ratio of 3:1.
With a market capitalization of Rs 9,962.10 crore, the shares of Metropolis Healthcare Ltd were trading at Rs 1,922.00 per share, increasing around 2 percent as compared to the previous closing price of Rs 1,891.25 apiece.
Q3FY26 Highlights
The shares of Metropolis Healthcare Ltd have seen significant movement after announcing its financial performance in Q3FY26, in which revenue increased by 26 percent on a year-on-year basis from Rs 323 crore in Q3FY25 to Rs 406 crore in Q3FY26. However, on a Quarter-on-Quarter basis, revenue decreased by 5 percent from Rs 429 crore in Q2FY26 to Rs 406 crore in Q3FY26.
Moreover, net profit increased by 35 percent on a yearly basis from Rs 31 crore in Q3FY25 to Rs 42 crore in Q3FY26, meanwhile, on a quarter-on-quarter basis, net profit decreased by 21 percent from Rs 53 crore in Q2FY26 to Rs 42 crore in Q3FY26.
The company delivered a strong Q3FY26 performance, with patient volumes rising 14% and test volumes up 13% YoY, reflecting steady demand and deeper penetration in Tier II and III markets. B2C revenue grew 19% while B2B surged 35%, supported by network expansion and improved execution. TruHealth and Specialty segments posted robust growth of 37% and 34%, respectively.
Realisations remained firm, with revenue per test and per patient increasing 11% and 10% YoY, driven by a better test mix and higher adoption of advanced diagnostics. North India contributed 17% to revenue, while Tier III cities accounted for 24% with 16% growth. Recent acquisitions were integrated smoothly, maintaining stable margins.
Additionally, the board approved and recommended the issuance of bonus equity shares in the proportion of 3:1, i.e., 3 fully paid-up equity shares of face value of Rs 2 each for every 1 fully paid-up equity share of face value of Rs 2 each held by the members on the record date, subject to members’, statutory and regulatory approvals, as applicable.
The diagnostics sector in India is at a pivotal inflection point, driven by the growing adoption of preventive healthcare, a rising chronic disease burden, and the expansion of organised healthcare across Tier II and Tier III markets. Our Q3 performance reflects how Metropolis is capturing these opportunities through a clear strategic focus and sustained investments in specialised capabilities. As our genomics and advanced diagnostics platforms scale, we are building a science-led, resilient, and future-ready diagnostics institution that meaningfully advances clinical decision-making and delivers enduring value for patients, clinicians, and the wider healthcare ecosystem.” ~ Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited.
Metropolis Healthcare is one of India’s leading diagnostic chains, offering a wide range of pathology and specialized testing services. With a strong presence across metros and Tier II and III cities, the company focuses on advanced diagnostics, quality standards, and expanding its network to deliver accessible and reliable healthcare solutions nationwide.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 3:1 Bonus Issue: Stock Jumps After Announcing Robust Q3 Results and Bonus Shares appeared first on Trade Brains.